Duncker Streett & Co’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
Other funds holding ELV
Duncker Streett & Co's ELV Position: Q3 2025 in Review
Duncker Streett & Co sold out of Elevance Health (ELV) in Q3 2025, closing a stake of 150 shares — an estimated $58.3K sold.
Duncker Streett & Co first reported a position in ELV in Q4 2019 and held it in 23 quarters. The position peaked at $3.95M in Q4 2022. 1,511 funds tracked by Wall St. Rank hold ELV as of Q3 2025.
- Duncker Streett & Co reported no remaining Elevance Health position as of Q3 2025 after selling out during the quarter.
- Duncker Streett & Co sold 150 Elevance Health shares in Q3 2025, an estimated $58.3K.
- Duncker Streett & Co first reported a position in Elevance Health in Q4 2019 and held it in 23 quarters.
- Duncker Streett & Co's Elevance Health position peaked at $3.95M in Q4 2022.
- 1,511 funds tracked by Wall St. Rank held Elevance Health as of Q3 2025.
Based on Duncker Streett & Co's 13F filing for Q3 2025, filed 23 Oct 2025.